Hypolipidemic agent - PDFSEARCH.IO - Document Search Engine

Hypolipidemic agent
Results: 26

#	Item
1	5.6 EZETIMIBE + ROSUVASTATIN, tablets, ezetimibe 10mg + rosuvastatin 5mg; ezetimibe 10mg + rosuvastatin 10mg; ezetimibe 10mg + rosuvastatin 20mg; ezetimibe 10mg + rosuvastatin 40mg, Rosuzet®, Merck Sharp & Dohme Austr Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Schering-Plough Statins Ezetimibe Lactams Organofluorides Rosuvastatin Simvastatin Hypolipidemic agent Merck & Co. Chemistry Organic chemistry Merck
2	Treatment injury case study October 2008 Sharing information to enhance patient safety EVENT: Add to Reading List Source URL: www.acc.co.nz Language: English - Date: 2014-09-30 23:37:35 Merck Lactones Fibrates Organochlorides Simvastatin Rosuvastatin Fenofibrate Hypolipidemic agent Myopathy Chemistry Organic chemistry Statins
3	CV RISK REDUCTION IN CANADAThe 2006 Canadian Cardiovascular Society Dyslipidemia recommendations acknowledge that both primary and secondary prevention interventions are required to maximize the health of Canadian Add to Reading List Source URL: www.diabetesclinic.ca Language: English - Date: 2009-03-30 11:47:28 Statins Fibrates Lactones Cardiology Lipoproteins Hypolipidemic agent Low-density lipoprotein Hypercholesterolemia Atherosclerosis Chemistry Medicine Health
4	5.4 EZETIMIBE + ATORVASTATIN fixed dose combination tablets; 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg; Atozet®; Merck Sharp & Dohme (Australia) Pty Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Schering-Plough Medicine Statins Pharmacology Ezetimibe Lactams Rosuvastatin Simvastatin Hypolipidemic agent Chemistry Organic chemistry Merck
5	Microsoft Word - MSD- 5-6 ezetimibe and rosuvastatinPSD final .docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Schering-Plough Statins Ezetimibe Lactams Organofluorides Rosuvastatin Simvastatin Hypolipidemic agent Merck & Co. Chemistry Organic chemistry Merck
6	Public Summary Document – November 2014 PBAC Meeting 5.4 EZETIMIBE + ATORVASTATIN fixed dose combination tablets; Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Schering-Plough Medicine Statins Pharmacology Organofluorides Ezetimibe Rosuvastatin Simvastatin Hypolipidemic agent Chemistry Organic chemistry Merck
7	Safety and life-saving efficacy of statins have been exaggerated, says USF scientist Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-04-17 03:32:33 Clinical trials Statins Statin Cardiology Rosuvastatin Hypolipidemic agent JUPITER trial Cholesterol Heart Protection Study Chemistry Organic chemistry Medicine
8	OUTCOMES RESEARCH IN REVIEW “Tailored Treatment” with Statins for Primary Prevention of Cardiovascular Disease May Be More Effective Than the Current “Treat-to-Target” LDL Strategy Hayward R, Krumholz H, Zulman Add to Reading List Source URL: www.turner-white.com Language: English Statins Cardiology Lipoproteins Low-density lipoprotein Lactones Merck Hypercholesterolemia Cholesterol Hypolipidemic agent Chemistry Organic chemistry Medicine
9	Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD Add to Reading List Source URL: phys.org Language: English - Date: 2015-03-03 14:27:32 Graft-versus-host disease Statin Hematopoietic stem cell transplantation Cholesterol Immunosuppressive drug Hypolipidemic agent Juvenile myelomonocytic leukemia Medicine Health Transplantation medicine
10	OUTCOMES RESEARCH IN REVIEW Diet and Exercise for Dyslipidemia: The Challenge of Putting Guidelines into Practice Lalonde L, Gray-Donald K, Lowensteyn I, Marchand S, et al. Comparing the benefits of diet and exercise in Add to Reading List Source URL: www.turner-white.com Language: English Lipoproteins Medicine Nutrition High-density lipoprotein Low-density lipoprotein Cholesterol Hypolipidemic agent Hypercholesterolemia Cardiovascular disease Chemistry Health Cardiology